NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Thursday 23 October 2008

FDA inspection rate is slow

The US Congress has revealed that FDA oversight of foreign plants producing pharmaceutical products for the US market leaves a lot to be desired. The investigation revealed that at current rates it will take 13 years to inspect the 3,249 plants currently providing products. The FDA takes about 2 years to inspect the 3,000 plants in the US.
Associated Press

No comments: